Research Project
Grant-in-Aid for Scientific Research (C)
We evaluated the feasibility of bone marrow stem cell-based enzyme replacement therapy (ERT) for hypophosphatasia model mice (Akp2-/- mice). Bone marrow stem cells transduced with bone-targeted form of tissue-nonspecific alkaline phosphatase (TNALP-D10) gene was intravenously transplanted into neonatal Akp2-/- mice on day 2 after birth. The treated Akp2-/- mice showed significantly prolonged survival with improved bone mineralization. These results provided us important insight regarding development of novel regenerative and cell therapy for inherited metabolic diseases including hypophosphatasia.
All 2016 2015 2014 2013
All Journal Article (3 results) (of which Int'l Joint Research: 1 results, Peer Reviewed: 3 results, Open Access: 1 results, Acknowledgement Compliant: 1 results) Presentation (10 results) (of which Int'l Joint Research: 2 results)
Molecular Therapy- Methods & Clinical Development
Volume: 3 Pages: 15059-15059
10.1038/mtm.2015.59
Hum Gene Ther.
Volume: 26 Issue: 12 Pages: 801-12
10.1089/hum.2015.078
Bone
Volume: 60 Pages: 93-97
10.1016/j.bone.2013.12.009